Founder of Corporate Governance Partners (http://www.cgfunding.com), co-founder, seed investor and President of Diagnomics (http://www.diagnomics.com), Managing Member at Genautica (http://www.genautica.com), with over 30 years experience in the Biotech Industry in San Diego, CA. Was the Chief Technology Officer (CTO) at PharMingen (91-97) and the VP of R&D at Becton Dickinson (97-00). Founder of Orbigen (00-04). Involved in several mergers and acquisitions in the $200+ MM range.Academic degree: MD / PhD (summa cum laude, Best-Thesis-Of-The-Year Award). Involved in technology scouting and evaluation for over 25 years.Initiator and curator of popular Science Newsletter (http://www.scoop.it/t/amazing-science) with over 900,000 reads. Fluent in English and German. Studied Human Medicine, Biology and Physics at the Johann-Wolfgang-Goethe University in Frankfurt / Germany. Broad scientific knowledge in many disciplines, including Biotechnology, Nanotechnology, Physics and Mathematics.Specialties: Biotechnology management, start-up company management, Fortune 100 company management, mergers and acquisitions, Venture Capital, Private Equity, Funds of Funds, International contacts, Russia, China. Nanotechnology Investment. Computer skills: Assembly language, HTML5, CSS3, Javascript, jQuery, PHP, MySQL, UNIX and Python (daily programming).You can email me ([email://sgruenwald@cgfunding.com]) and find me on LinkedIn (sgruenwald), Twitter (@sgruenwald), Pinterest (genautica), Rebelmouse (sgruenwald) and SKYPE (esmestefan).RECENT PRESS RELEASE: https://tinyurl.com/y4xcr3qt